Previously, miRNA miR-129-5p mimetic treatment was able to slow down the progression of myocardial hypertrophy and restore systolic and diastolic dysfunction in angiotensin II (AngII)-induced heart failure mice [17]. This evidence concerns the gene AGT and cardiac hypertrophy.